Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects
Clinical trial NCT06678542 · COMPLETED
Trial details
- NCT number
- NCT06678542
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-27
- Primary completion
- 2025-02-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.